中国专利医学作为2型糖尿病的补充和替代疗法:一个范围审查
Hai-Zhu Zheng1, Tian-Ying Chang2, Bo Peng3
1College of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China; Center for Evidence-based Chinese Medicine, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
中国专利药 (CPM) 为2型糖尿病 (T2DM) 管理提供了各种选择. 需要进一步的研究来规范它们与传统治疗的使用,并建立明确的结果指标.
科学领域:
- 整合和补充医学是整合和补充医学.
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 中国专利药物 (CPM) 越来越多地被用于治疗慢性疾病.
- 2型糖尿病 (T2DM) 是一个重大的全球健康挑战.
- 了解T2DM的CPM格局对于基于证据的实践至关重要.
研究的目的:
- 为了记录T2DM的可用CPM.
- 评估CPM对患者健康结果的影响.
- 确定T2DM的研究重点和CPM中的差距.
主要方法:
- 根据PRISMA-SCr指南进行范围审查.
- 在八个数据库中进行系统的文献搜索 (开始至2023年6月).
- 数据提取和对T2DM的CPM研究的分析.
主要成果:
- 对T2DM确定了25种类型的CPM;Radix astragali是常见的成分.
- 分析了449篇文章,重点关注20个CPM类型.
- CPMs通常与口服低血糖药,特别是大瓜尼德 (biguanides) 一起使用.
结论:
- 对于T2DM存在各种各样的CPM,但证据质量各不相同.
- 需要将CPM与传统医学相结合的标准化.
- 未来的研究应该专注于一致的结果措施.
更多相关视频
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
